NXGN NextGen Healthcare Dashboard

NextGen Healthcare, Inc. is an American software and services company headquartered in Irvine, California, US. The company develops and sells electronic health record software and practice management systems to the healthcare industry. NextGen Healthcare also provides population health, financial management, and clinical solutions for medical and dental practices. On September 7, 2018, Quality Systems Inc. changed its name to Nextgen Healthcare, Inc. and on September 10, their stock ticker symbol changed to NASDAQ: NXGN.[citation needed] Quality Systems, Inc. was formed by Sheldon Razin in 1974 in Irvine, California, as a dental software company. In 1994, Clinitec was formed by Pat Cline and Bryan Rosenberger to sell software for converting paper medical records into electronic medical records. Clinitec was purchased by QSI in 1996.

Company profile

Ticker

NXGN

Exchange

NASDAQ

Website

www.nextgen.com

CEO

John Rusty Frantz

Incorporated

California

Location

Georgia

Fiscal year end

Mar 31

Sector

Professional, Scientific, and Technical Services > Computer Systems Design Services

Industry (SIC)

Services - Computer Integrated Systems Design

Leidos • Godaddy • Unisys • Parsons • Cerner • Allscripts Healthcare Solutions • Caci International Inc. - Registered Shares • Open Text • Jack Henry & Associates • Verint Systems ...

Former names

QUALITY SYSTEMS INC, QUALITY SYSTEMS, INC

SEC CIK

0000708818

Corporate docs

Articles of Incorporation & Bylaws

IRS number

952888568

NXGN stock data

S&P 500

1M 1Y 2Y 5Y

News

Pro users get this 30m faster

SVB Leerink Maintains Market Perform on NextGen Healthcare, Raises Price Target to $22

28 Jan 21

SVB Leerink analyst Stephanie Davis maintains NextGen Healthcare (NASDAQ:NXGN) with a Market Perform and raises the price target from $21 to $22.

Morgan Stanley Maintains Underweight on NextGen Healthcare, Raises Price Target to $18

28 Jan 21

Morgan Stanley analyst Ricky Goldwasser maintains NextGen Healthcare (NASDAQ:NXGN) with a Underweight and raises the price target from $14 to $18.

NextGen Healthcare Q3 Adj. EPS $0.26 Beats $0.25 Estimate, Sales $141.80M Beat $140.88M Estimate

27 Jan 21

NextGen Healthcare (NASDAQ:NXGN) reported quarterly earnings of $0.26 per share which beat the analyst consensus estimate of $0.25 by 4 percent. This is a 13.04 percent increase over earnings of $0.23 per share from the

Earnings Scheduled For January 27, 2021

27 Jan 21

Stocks That Hit 52-Week Highs On Monday

25 Jan 21

Press releases

Pro users get this 30m faster

NextGen Healthcare Teams up with Renowned Psychiatrist Dr. Gail Saltz to Pave Paths to Mental Health Resources Through #NextGenMind Campaign

15 Apr 21

NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, announced that it is partnering with well-known psychiatrist Dr. Gail Saltz to spotlight the importance of access to

NextGen Healthcare's Milestone Release Strengthens the Patient-Provider Connection

6 Apr 21

NextGen® Enterprise Spring '21 Release Enables Tightly Integrated Clinical, Financial and Patient Experience While Supporting 21st Century Cures Act Requirements NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading

85% Of Specialty Provider Organizations Shifting Towards Primary Care - The New Survey Results From NextGen & OPEN MINDS

24 Feb 21

GETTYSBURG, Pa., Feb. 24, 2021 /PRNewswire/ -- Eighty-five percent of behavioral health and intellectual and developmental disability providers say they are broadening their practices to include primary care services,

NextGen Healthcare's Revenue Cycle Management Services Adopted by Loden Vision Centers

8 Feb 21

NextGen Healthcare, Inc. Reports Fiscal 2021 Third Quarter Results

27 Jan 21

Investment data

Data from SEC filings

Securities sold

Number of investors

Calendar

27 Jan 21

18 Apr 21

31 Mar 22

Financial summary

Financial statements Chart NXGN financial data

Quarter (USD)	Dec 20	Sep 20	Jun 20	Dec 19
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Annual (USD)	Mar 20	Mar 19	Mar 18	Mar 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Recent insider trades

NXGN insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
12 Apr 21	Craig A. Barbarosh	Common Stock	Sell	Dispose S	No	Yes	18.7047	9,000	168.34K	90,946
22 Mar 21	Frantz John R	Common Stock	Sell	Dispose S	No	Yes	18.9938	25,000	474.85K	438,328
9 Feb 21	Rosenzweig Lance	Common Stock	Sell	Dispose S	No	No	20.8836	6,000	125.3K	35,782
9 Feb 21	Rosenzweig Lance	Common Stock	Sell	Dispose S	No	No	20.767	6,000	124.6K	41,782
8 Feb 21	Rosenzweig Lance	Common Stock	Sell	Dispose S	No	No	20.5196	12,000	246.24K	47,782
4 Feb 21	Frantz John R	Common Stock	Sell	Dispose S	No	Yes	19.8139	25,000	495.35K	463,328
3 Feb 21	David Ahmadzai	Common Stock	Sell	Dispose S	No	No	19.6122	10,446	204.87K	31,006
3 Feb 21	David Ahmadzai	Common Stock	Option exercise	Aquire M	No	No	16.83	3,000	50.49K	41,452
3 Feb 21	David Ahmadzai	Common Stock	Option exercise	Aquire M	No	No	16.64	1,500	24.96K	38,452
3 Feb 21	David Ahmadzai	Common Stock	Option exercise	Aquire M	No	No	16.37	3,250	53.2K	36,952

Data from 3, 4 and 5 filings. Stock values as filed, not updated for current price.

Institutional ownership Q4 2020

NXGN institutional ownership history Ownership history

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders	Current	Prev Q	Change
Total holders	0	1	EXIT
Opened positions	0	0
Closed positions	0	0
Increased positions	0	0
Reduced positions	0	0

13F shares	Current	Prev Q	Change
Total value	0	0
Total shares	0	0
Total puts	0	0
Total calls	0	0
Total put/call ratio	–	–	–

Largest owners	Shares	Value	Change

Largest transactions	Shares	Bought/sold	Change
IFP Advisors	0	0

Data from 13F filings. Stock values as filed, not updated for current price. Long positions only.

Financial report summary

Competition

Cerner • Allscripts Healthcare Solutions

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: discretionary, merit, postponed, relevant, retired, Scope

Removed: adjudication, assuming, bench, denied, finalize, July, leaving, noticed, overruled, petition, petitioned, plaintiff, practicable, preliminary, reconsideration, rehear, rehearing, renewed, Supreme

From filing 10-Q 2021 Q3